ARCHIVES

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

This article is from The Cancer Letter archive.

Vol. 29 No. 02 | January 10, 2003

Download PDF Visit The Full Archive

Related Articles

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

Caris Life Sciences Lays Off Estimated 20 Percent of Staff

October 24, 2014

Black Women More Likely To Delay Diagnosis, Treatment

July 29, 2005

Prospects Fading for Funding More CCOPsIn FY ’83; Return to Groups Of Money From Satellites Going To New Programs

July 29, 1983

Biological Modifiers Journal Objects To NEJ Policy, Says It Will OK Clinical Data Release

April 26, 1985

In Brief: DeVita Changes His Mind, Agrees To Head Treatment DIV; Contracts Chief Carl Fretts Moves Up To NIH

October 4, 1974